MeitY Startup Hub onboards MergerDomo to strengthen start-up ecosystem in India
Posted By - Investment Banker
EU GMP approved pharmaceutical contract research and manufacturing facility located in Himachal Pradesh having a manufacturing capacity of 300 million plus doses in a month. Varied and customizable manufacturing capabilities. Also having Export license and international approvals in place.
Deal Size
INR 112.5 - 120 Cr
Motives For Sellout
Strategic Realignment
Industry
Pharmaceuticals
Sub-Industry
Contract Research & Manufacturing Services (CRAMS)
Entity is open for Investor Keen on Special Situations/distress assets funding
Management is open to continue with the business for handholding the new investor/buyers
Industry
Pharmaceuticals
Sub-Industry
Contract Research & Manufacturing Services (CRAMS)
Division
Division`s Buyers/Customers
| 2017 (in Cr) | 2018 (in Cr) | 2019 (in Cr) | 2020 (in Cr) | ||
|---|---|---|---|---|---|
| Sales | N.D | N.D | INR 10 Cr | INR 12 Cr | |
| EBITDA | N.D | N.D | N.D | N.D | |
| PAT | N.D | N.D | N.D | N.D | |
| TOTAL DEBT | N.D | N.D | N.D | N.D | |
If you are interested to connect with this party, please send an Expression of Interest and receive Information Memo to take this opportunity further
Business Model
